Boston Scientific
867 hedge funds and large institutions have $55.3B invested in Boston Scientific in 2021 Q2 according to their latest regulatory filings, with 102 funds opening new positions, 305 increasing their positions, 309 reducing their positions, and 58 closing their positions.
76% more first-time investments, than exits
New positions opened: 102 | Existing positions closed: 58
10% more capital invested
Capital invested by funds: $50.1B → $55.3B (+$5.21B)
4% more funds holding
Funds holding: 830 → 867 (+37)
0.32% less ownership
Funds ownership: 91.43% → 91.12% (-0.32%)
1% less repeat investments, than reductions
Existing positions increased: 305 | Existing positions reduced: 309
8% less call options, than puts
Call options by funds: $358M | Put options by funds: $387M
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$717M |
| 2 |
Parnassus Investments
San Francisco,
California
|
+$263M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$195M |
| 4 |
Two Sigma Advisers
New York
|
+$186M |
| 5 |
Two Sigma Investments
New York
|
+$164M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$542M |
| 2 |
FP
Financial Perspectives
Minneapolis,
Minnesota
|
-$269M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$193M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$164M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
-$151M |
BSX Hedge Fund Activity: Q2 2021 in Review
867 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2021, worth a combined $55.3B — up 10% from $50.1B a quarter earlier.
Buyers outnumbered sellers: 102 funds opened new BSX positions and 58 closed out — a net gain of 44 holders — while 305 added to existing stakes and 309 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $717M. The largest seller was BlackRock, cutting an estimated $542M.
- 867 institutional investors held Boston Scientific (BSX) as of Q2 2021, up from 830 in Q1 2021.
- Funds reported $55.3B of Boston Scientific stock for Q2 2021, up 10% quarter-over-quarter.
- 102 funds opened new Boston Scientific positions in Q2 2021 and 58 closed out, a net change of +44 holders.
- The largest Boston Scientific buyer in Q2 2021 was Fidelity Investments, an estimated $717M added.
- The largest Boston Scientific seller in Q2 2021 was BlackRock, an estimated $542M sold.
Based on aggregated 13F filings for Q2 2021.